Rheumatology
Shibley Rahman, Avinash Sharma in MRCP Part 2 Best of Five Practice Questions, 2018
Rheumatology is concerned with the science behind the presentation, investigations, and management of common conditions for the MRCP. Common conditions are reflected in the frequency of their questions, i.e. inflammatory arthritis, back pain, periarticular disorders, osteoarthritis, connective tissue diseases, and bone diseases. However, all candidates must be able to answer questions on the management of acute rheumatological emergencies, including septic arthritis, osteomyelitis, temporal arteritis and acute spinal cord compression.
A Resistance and Everyday View on Health Care Professionals
Anne Reff Pedersen in Making Sense of Organizational Change and Innovation in Health Care, 2019
This chapter demonstrates how resistance to everyday innovation and organizing can be explained through observation of interactions and identifying the local values of health care professionals. It aims to understand the role of health care professionals in everyday innovation, investigates their local interactions in daily routines as well as identify their local values, as they will indicate whether the health care professionals would be inclined to participate in new change projects or be likely to resist. The chapter presents an organizational ethnography at a rehabilitation hospital. The hospital was responsible for the rehabilitation of patients following treatment in orthopedic, rheumatologic, medical, and neurological wards in other hospitals. The narrative analysis includes individual structured narratives and more fragmented individual ante-narratives. Sociological studies of professions in health care have illustrated many important topics examining the formation of the medical professions and the general processes of professionalism in health care.
Musculoskeletal disorders (and rheumatology)
Shibley Rahman, Avinash Sharma in A Complete MRCP(UK) Parts 1 and 2 Written Examination Revision Guide, 2018
This chapter details what is required in terms of competencies, skills and knowledge from junior physicians in core medical training in musculoskeletal disorders/rheumatology. Cryoglobulins are immunoglobulins which undergo reversible precipitation at 4°C, dissolve when warmed to 37°, One-third of cases are idiopathic. Psoriatic arthropathy correlates poorly with cutaneous psoriasis and often precedes the development of skin lesions. Around 10% of patients with skin lesions develop an arthropathy, with males and females being equally affected. Reactive arthritis is one of the HLA-B27 associated seronegative spondyloarthropathies. Behcet's syndrome is a complex multisystem disorder associated with presumed autoimmune mediated inflammation of the arteries and veins. Polyarteritis nodosa (PAN) is a vasculitis affecting medium-sized arteries with necrotising inflammation leading to aneurysm formation. PAN is more common in middle-aged men and is associated with hepatitis B infection. Wegener's granulomatosis is an autoimmune condition associated with a necrotising granulomatous vasculitis, affecting both the upper and lower respiratory tract as well as the kidneys.
A comparative clinical study of temporomandibular disorder patients in the otolaryngology clinic versus a rheumatology clinic
Published in CRANIO®, 2019
Objective Temporomandibular disorders (TMD) may be associated with local or widespread symptoms, including pain. The aim of this study was to compare clinical features of TMD patients presenting to an otolaryngology clinic with TMD patients presenting to a rheumatology clinic. Methods The study included 107 patients in the otolaryngology setting and 103 patients in the rheumatology setting. A comparison between both groups was made regarding the clinical data. Results Patients in the otolaryngology setting featured more otological symptoms, compared with those in the rheumatology setting. Otological symptoms were affirmed in 70 patients (65.4%) in the otolaryngology setting but in only 18 patients (17.5%) in the rheumatology setting (p = 0.001). Patients in the rheumatology setting showed more structural TMJ changes, compared with those in the otolaryngology setting (p
Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases
Published in Annals of Medicine, 2016
Ripalta Colìa, Addolorata Corrado, Francesco Paolo Cantatore
Inflammatory bowel diseases (IBDs) often present as a complex inflammatory process wherein colon lesions (ulcerative colitis, UC) or widespread ulceration and fissure (Crohn’s disease, CD) might be accompanied by ancillary extraintestinal manifestations (EIMs) that could involve almost every organ system, but also by autoimmune disorders ranging from psoriasis and rheumatoid arthritis to connective tissue diseases. Certain EIMs are more common related to the activity of the IBD (joint, skin, ocular and oral manifestations), other EIMs typically run a course independent of the IBD activity (hepatobiliary disorders) and some are non-specific disorders (osteoporosis and amyloidosis). This paper reviews the most common extraintestinal and rheumatologic manifestations of UC and CD. They may produce greater morbidity than the underlying intestinal disease and may even be the initial presenting symptoms of the IBD. Thus, early recognition of these manifestations should help guide therapy that will reduce overall morbidity in affected patients. Key MessageA complete review on the most common extraintestinal and rheumatologic manifestations of ulcerative colitis and Crohn’s disease.
Discontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary
Published in Expert Opinion on Investigational Drugs, 2011
This is the annual perspective paper on the discontinued drugs in the field of pulmonary disease allergy, rheumatology, and dermatology. It is part of series of papers discussing drugs dropped from clinical development in the previous year and presented according to therapeutic indication. Specifically, this paper presents the four rheumatology and dermatology, four pulmonary and three allergy drugs discontinued in 2010. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I – III clinical trials.
Related Knowledge Centers
- Diagnosis
- Internal Medicine
- Joint
- Soft Tissue
- Rheumatism
- Pediatrician
- Therapy